Feb 4, 2024
The renowned clinical-stage biotech company PharmAust (ASX: PAA) is all set for a new program focusing on its trials for the primary drug ca
seen from Russia
seen from Türkiye
seen from United States
seen from United Kingdom
seen from Mexico
seen from United States
seen from Germany
seen from China
seen from Bangladesh
seen from Russia
seen from Russia
seen from Brazil
seen from Ukraine
seen from United States
seen from Germany
seen from Russia
seen from Spain
seen from Türkiye
seen from Canada
seen from United States
The renowned clinical-stage biotech company PharmAust (ASX: PAA) is all set for a new program focusing on its trials for the primary drug ca